FOLFOXIRI vs FOLFOX/FOLFIRI + bevacizumab in patients with initially unresectable colorectal liver metastases and right-sided and/or RAS/BRAFV600E mutated primary tumor: phase III CAIRO5 study

European Journal of Surgical Oncology(2023)

引用 0|浏览14
暂无评分
关键词
unresectable colorectal liver metastases,bevacizumab,folfoxiri,primary tumor,right-sided
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要